PROTEOGENOMIC ANALYSIS OF RESPONDERS VERSUS NONRESPONDERS IN A PHASE 1 TRIAL OF TH17-INDUCING DENDRITIC CELL VACCINATION FOR ADVANCED-STATE OVARIAN CANCER
$296,178FY2021Defense Health AgencyDOD
University Of Arkansas For Medical Sciences
University Of Arkansas For Medical Sciences